Evidence map›Paper›PMID 30042337›Full record

ArticleInternational journal of molecular sciences2018

Antibacterial and Biofilm Modulating Potential of Ferulic Acid-Grafted Chitosan against Human Pathogenic Bacteria.

Chakradhar Dasagrandhi, Seulki Park, Won-Kyo Jung, Young-Mog Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Green Biocatalysis of Xylitol Monoferulate:Biotech (Basel (Switzerland)) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Applications of Chitosan and its Derivatives in Skin and Soft Tissue Diseases.Frontiers in bioengineering and biotechnology · 2022
    Review
  13. UsingFrontiers in pharmacology · 2022
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chakradhar DasagrandhiMarine-Integrated Bionics Research Center, Pukyong National University, Busan 48513, Korea. dasagrandhichakradhar@gmail.com.
Seulki ParkDepartment of Food Science and Technology, Pukyong National University, Busan 48513, Korea. moojuk87@gmail.com.
Won-Kyo JungDepartment of Biomedical Engineering, Pukyong National University, Busan 48513, Korea. wkjung@pknu.ac.kr.ORCID 0000-0002-1615-750X
Young-Mog KimMarine-Integrated Bionics Research Center, Pukyong National University, Busan 48513, Korea. ymkim@pknu.ac.kr.ORCID 0000-0002-2465-8013
Pukyong National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of more virulent forms of human pathogenic bacteria with multi-drug resistance is a serious global issue and requires alternative control strategies. The current study focused on investigating the antibacterial and antibiofilm potential of ferulic acid-grafted chitosan (CFA) against

Indexed as

Anti-Bacterial AgentsBiofilmsCell Membrane PermeabilityCell MovementCell SurvivalChitosanCoumaric AcidsDose-Response Relationship, DrugHumansListeria monocytogenesMicrobial Sensitivity TestsPseudomonas aeruginosaStaphylococcus aureusAnti-Bacterial AgentsChitosanCoumaric Acidsferulic acidantibacterial agentantibiofilmferulic acid grafted chitosanhuman pathogenic bacteria

Identifiers

PMID30042337
PMCPMC6121546
OpenAlexW2883680479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.